XS
LABU icon

XR Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

XR Securities’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-379
Closed -$380K – 278
2019
Q2 		$380K Buy
+379
New +$367K 0.07% 90

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

XR Securities's LABU Position: Q3 2019 in Review

XR Securities sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2019, closing a stake of 379 shares — an estimated $380K sold.

XR Securities first reported a position in LABU in Q2 2019 and held it in 1 quarter. The position peaked at $380K in Q2 2019. 21 funds tracked by Wall St. Rank hold LABU as of Q3 2019.

  • XR Securities reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2019 after selling out during the quarter.
  • XR Securities sold 379 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2019, an estimated $380K.
  • XR Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2019 and held it in 1 quarter.
  • XR Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $380K in Q2 2019.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2019.

Based on XR Securities's 13F filing for Q3 2019, filed 3 Oct 2019.